
Inquisite provides enterprise-grade, human-in-the-loop AI tools purpose-built for life sciences R&D teams. Their platform aims to accelerate the path from research to market by transforming evidence synthesis, clinical trial design, and medical writing. Key products include a Research Assistant for systematic literature reviews, a Document Builder for research proposals and grant applications, and a Clinical Trial Designer. Inquisite leverages a comprehensive biomedical research knowledge graph to help teams synthesize evidence, reduce time spent on literature reviews by over 80%, and ensure no insights are missed. The company operates as a Public Benefit Corporation, founded by professors from Duke University, and is based in North Carolina's Research Triangle Park.

Inquisite provides enterprise-grade, human-in-the-loop AI tools purpose-built for life sciences R&D teams. Their platform aims to accelerate the path from research to market by transforming evidence synthesis, clinical trial design, and medical writing. Key products include a Research Assistant for systematic literature reviews, a Document Builder for research proposals and grant applications, and a Clinical Trial Designer. Inquisite leverages a comprehensive biomedical research knowledge graph to help teams synthesize evidence, reduce time spent on literature reviews by over 80%, and ensure no insights are missed. The company operates as a Public Benefit Corporation, founded by professors from Duke University, and is based in North Carolina's Research Triangle Park.